Follow this preprint
The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS)
View ORCID ProfileElise Dumas, View ORCID ProfileLucie Laot, View ORCID ProfileFlorence Coussy, View ORCID ProfileBeatriz Grandal Rejo, View ORCID ProfileEric Daoud, View ORCID ProfileEnora Laas, Amyn Kassara, View ORCID ProfileAlena Majdling, View ORCID ProfileRayan Kabirian, View ORCID ProfileFloriane Jochum, View ORCID ProfilePaul Gougis, Sophie Michel, View ORCID ProfileSophie Houzard, View ORCID ProfileChristine Le Bihan-Benjamin, View ORCID ProfilePhilippe-Jean Bousquet, Judicaël Hotton, View ORCID ProfileChloé-Agathe Azencott, View ORCID ProfileFabien Reyal, View ORCID ProfileAnne-Sophie Hamy
doi: https://doi.org/10.1101/2022.03.14.22272286
Now published in Cancers doi: 10.3390/cancers14112671
Elise Dumas
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
2INSERM, U900, 75005 Paris, France
3MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France
Lucie Laot
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
Florence Coussy
5Department of Medical Oncology, Institut Curie, University of Paris, 75005 Paris, France
Beatriz Grandal Rejo
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
Eric Daoud
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
6INRIA, DI/ENS, PSL Research University, Paris, France
Enora Laas
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
Amyn Kassara
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
Alena Majdling
7Centre René Hughenin, Medical Oncology Department, 92210 Saint Cloud, France
Rayan Kabirian
7Centre René Hughenin, Medical Oncology Department, 92210 Saint Cloud, France
Floriane Jochum
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
8Department of gynecology, Strasbourg University Hospital, Strasbourg, France
Paul Gougis
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
Sophie Michel
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
Sophie Houzard
9Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 92100 Boulogne-Billancourt, France
Christine Le Bihan-Benjamin
9Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 92100 Boulogne-Billancourt, France
Philippe-Jean Bousquet
10Aix Marseille Univ, Inserm, IRD, SESSTIM, Equipe Labellisée Ligue Contre le Cancer, 13005 Marseille, France
11Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 92100 Boulogne-Billancourt, France
Judicaël Hotton
12Department of Surgery, Institut Jean Godinot, Reims, France
Chloé-Agathe Azencott
3MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France
13Institut Curie, PSL Research University, 75005 Paris, France
2INSERM, U900, 75005 Paris, France
Fabien Reyal
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
12Department of Surgery, Institut Jean Godinot, Reims, France
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
Anne-Sophie Hamy
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
7Centre René Hughenin, Medical Oncology Department, 92210 Saint Cloud, France
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Posted March 14, 2022.
The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS)
Elise Dumas, Lucie Laot, Florence Coussy, Beatriz Grandal Rejo, Eric Daoud, Enora Laas, Amyn Kassara, Alena Majdling, Rayan Kabirian, Floriane Jochum, Paul Gougis, Sophie Michel, Sophie Houzard, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Judicaël Hotton, Chloé-Agathe Azencott, Fabien Reyal, Anne-Sophie Hamy
medRxiv 2022.03.14.22272286; doi: https://doi.org/10.1101/2022.03.14.22272286
Now published in Cancers doi: 10.3390/cancers14112671
Subject Area
Subject Areas
- Addiction Medicine (407)
- Allergy and Immunology (718)
- Anesthesia (213)
- Cardiovascular Medicine (3030)
- Dermatology (256)
- Emergency Medicine (453)
- Epidemiology (12949)
- Forensic Medicine (12)
- Gastroenterology (845)
- Genetic and Genomic Medicine (4755)
- Geriatric Medicine (439)
- Health Economics (745)
- Health Informatics (3019)
- Health Policy (1091)
- Hematology (405)
- HIV/AIDS (950)
- Medical Education (448)
- Medical Ethics (118)
- Nephrology (488)
- Neurology (4531)
- Nursing (241)
- Nutrition (669)
- Oncology (2353)
- Ophthalmology (665)
- Orthopedics (262)
- Otolaryngology (332)
- Pain Medicine (294)
- Palliative Medicine (85)
- Pathology (511)
- Pediatrics (1226)
- Primary Care Research (513)
- Public and Global Health (7118)
- Radiology and Imaging (1579)
- Respiratory Medicine (939)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (502)
- Toxicology (63)
- Transplantation (217)
- Urology (187)